<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Noven Pharmaceuticals Inc. | Company News & Executive Profiles - NOVN | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Noven Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="19" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Noven Pharmaceuticals, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-280162.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. We'll now be conducting a question-and-answer session. Operator instructions Our first question comes from Tim Chiang from FTN Equity Capital. Please pose your question. Tim Chiang &#8211; FTN Equity Capital Thanks. You mentioned an FDA green light requirement for the Daytrana patch. What does that,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 20 Mar 2009 03:17:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
	<item>
		<title><![CDATA[Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-252026.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Certainly. Ladies and gentlemen, at this time, we'll be conducting the question-and-answer session. Operator instructions. Our first question will come from Patti Bank with Pacific Growth Equities. Patti Bank &#8211; Pacific Growth Equities Thanks for the update information, it was very helpful. Just two questions, one on...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 24 Nov 2008 10:42:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
	<item>
		<title><![CDATA[Noven Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223354.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator instructions Our first question coming from Scott Henry of Roth Capital.  Scott Henry &#8211; Roth Capital  Thank you for taking the question. Just a couple of them. First, is there any thought on the lithium once-a-day product in terms of are you...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 12 Sep 2008 19:58:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
	<item>
		<title><![CDATA[Time to Invest in Pharmaceuticals?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F91356-time-to-invest-in-pharmaceuticals%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Howard Sun submits: The prices of many pharmaceutical companies have been beaten down by Wall Street in recent months. With companies like Pfizer PFE, Schering-Plough SGP and Bristol-Myers Squibb BMY reaching lower lows, one has to wonder when the pain will end as these companies are now significantly undervalued. The...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 17 Aug 2008 11:44:31 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">AZN,BMY,LLY,FRX,GSK,MRK,NVS,NOVN,PFE,SGP,WYE</category>
	</item>
	<item>
		<title><![CDATA[Banner Pharmacaps Receives FDA Approval for Valproic Acid Delayed Release Softgel Capsules]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_30/ai_n27952750]]></link>
		<description><![CDATA[HIGH POINT, N.C. -- Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin dosage form technology, today announced that the US Food & Drug Administration FDA has granted final approval for the Company's New Drug Application NDA for Valproic Acid Delayed Release soft gelatin...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 30 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/banner+pharmacaps+inc..html"><![CDATA[Banner Pharmacaps Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
	<item>
		<title><![CDATA[Noven Added to NASDAQ NeuroInsights Neurotech Index]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_25/ai_n27870863]]></link>
		<description><![CDATA[MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced today that it has been added to the NASDAQ([R]) NeuroInsights([R]) Neurotech Index (NASDAQ:NERV). The Neurotech Index is designed to track the performance of leading neurotechnology companies listed and actively traded on one of the three major U.S. stock exchanges.  The Neurotech Index...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 25 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NDAQ,NOVN</category>
	</item>
	<item>
		<title><![CDATA[Noven Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-226343.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Our first question comes from the line of Enrique Iribarne with Roth Capital Partners. Please go ahead with your question. Enrique Iribarne &#8211; Roth Capital Partners Good morning gentlemen. This is Enrique Iribarne for Scott Henry. I just have a couple of quick questions. Regarding...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 30 May 2008 03:04:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
	<item>
		<title><![CDATA[Noven Pharmaceuticals Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-228655.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Thank you. Ladies and gentlemen, we will now be conducting a question and answer session. Operator Instructions Our first question comes from the line of Tim Chiang. Please state your question.   Timothy Chiang- FTN Midwest Securities Corp. Hi thanks. I wanted to ask you...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 14 Apr 2008 12:55:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
	<item>
		<title><![CDATA[Noven to Report 2007 Fourth Quarter and Full Year Financial Results and Host Conference Call on March 27, 2008]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_24/ai_n24944103]]></link>
		<description><![CDATA[SEC Comment Resolved, Noven to Maintain Current Revenue Recognition Policy  MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that it will release its 2007 fourth quarter and full year financial results before the market opens on Thursday, March 27, 2008. Noven management will host a conference call that same...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 24 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
	<item>
		<title><![CDATA[Noven Pharmaceuticals Inc. Review in Progress.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25266986]]></link>
		<description><![CDATA[M2 PRESSWIRE-24 March 2008-MG Strategies: Noven Pharmaceuticals  Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD    RDATE:25032008    MaybachFinancial.com is one of the fastest growing independent and  unbiased research firms in the world. Investors wanting to know the  truth about investing and how to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 24 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/noven+pharmaceuticals+inc..html"><![CDATA[Noven Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
		<category domain="tickers">NOVN</category>
	</item>
</channel>
</rss>
